
Cap 1 N1meψ dCas9-VPR mRNA
dCas9-VPR is a modified version of the Cas9 protein used for gene regulation. It combines a deactivated Cas9 (dCas9) with a synthetic transcriptional activator complex called VPR, consisting of VP64, p65, and Rta domains. This fusion allows for precise and potent activation of gene expression at specific DNA sequences. dCas9-VPR is a valuable tool in various research applications, enabling targeted gene activation in studies of gene therapy, synthetic biology, and functional genomics. This mRNA possesses a Cap1 structure, which is highly efficient in capping. It is fully substituted with N1-methyl-pseudo Uridine to improve expression and decrease immunogenicity. Additionally, the mRNA features a 110A tail in its sequence, resembling a mature mRNA.